Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Novanta (NOVT) Research & Development (2016 - 2025)

Novanta's Research & Development history spans 16 years, with the latest figure at $22.9 million for Q4 2025.

  • For Q4 2025, Research & Development fell 9.56% year-over-year to $22.9 million; the TTM value through Dec 2025 reached $95.5 million, changed 0.03%, while the annual FY2025 figure was $95.5 million, 0.03% changed from the prior year.
  • Research & Development reached $22.9 million in Q4 2025 per NOVT's latest filing, down from $24.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $25.3 million in Q2 2025 to a low of $17.0 million in Q3 2021.
  • Average Research & Development over 5 years is $22.0 million, with a median of $22.8 million recorded in 2023.
  • Peak YoY movement for Research & Development: rose 27.33% in 2022, then dropped 9.56% in 2025.
  • A 5-year view of Research & Development shows it stood at $19.4 million in 2021, then rose by 12.8% to $21.9 million in 2022, then rose by 7.07% to $23.5 million in 2023, then grew by 7.82% to $25.3 million in 2024, then decreased by 9.56% to $22.9 million in 2025.
  • Per Business Quant, the three most recent readings for NOVT's Research & Development are $22.9 million (Q4 2025), $24.1 million (Q3 2025), and $25.3 million (Q2 2025).